- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Point-of-Care Molecular Diagnostics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Point-of-Care Molecular Diagnosticsmarket, defines the market attractiveness level of Point-of-Care Molecular Diagnostics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Point-of-Care Molecular Diagnostics industry, describes the types of Point-of-Care Molecular Diagnostics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Point-of-Care Molecular Diagnostics market and the development prospects and opportunities of Point-of-Care Molecular Diagnostics industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Point-of-Care Molecular Diagnostics market in Chapter 13.
By Player:
Becton Dickinson Co
Qiagen
Alere Inc
Siemens Healthcare GmbH
Novartis AG
Bio-Rad Laboratories Inc
Danaher Corporation
Bayer AG
By Type:
PCR-based
Genetic Sequencing-based
Hybridization-based
Microarray-based
By End-User:
Infectious Diseases
Oncology
Hematology
Prenatal Testing
Endocrinology
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Point-of-Care Molecular Diagnostics Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Point-of-Care Molecular Diagnostics Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Point-of-Care Molecular Diagnostics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Point-of-Care Molecular Diagnostics Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Point-of-Care Molecular Diagnostics Market Analysis and Outlook to 2022
-
7.1 Global Point-of-Care Molecular Diagnostics Consumption (2017-2022)
-
7.2 United States Point-of-Care Molecular Diagnostics Consumption (2017-2022)
-
7.3 Europe Point-of-Care Molecular Diagnostics Consumption (2017-2022)
-
7.4 China Point-of-Care Molecular Diagnostics Consumption (2017-2022)
-
7.5 Japan Point-of-Care Molecular Diagnostics Consumption (2017-2022)
-
7.6 India Point-of-Care Molecular Diagnostics Consumption (2017-2022)
-
7.7 South Korea Point-of-Care Molecular Diagnostics Consumption (2017-2022)
8 Region and Country-wise Point-of-Care Molecular Diagnostics Market Analysis and Outlook to 2028
-
8.1 Global Point-of-Care Molecular Diagnostics Consumption Forecast (2022-2028)
-
8.2 United States Point-of-Care Molecular Diagnostics Consumption Forecast (2022-2028)
-
8.3 Europe Point-of-Care Molecular Diagnostics Consumption Forecast (2022-2028)
-
8.4 China Point-of-Care Molecular Diagnostics Consumption Forecast (2022-2028)
-
8.5 Japan Point-of-Care Molecular Diagnostics Consumption Forecast (2022-2028)
-
8.6 India Point-of-Care Molecular Diagnostics Consumption Forecast (2022-2028)
-
8.7 South Korea Point-of-Care Molecular Diagnostics Consumption Forecast (2022-2028)
9 Global Point-of-Care Molecular Diagnostics Market Outlook by Types and Applications to 2022
-
9.1 Global Point-of-Care Molecular Diagnostics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global PCR-based Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Genetic Sequencing-based Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Hybridization-based Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Microarray-based Consumption and Growth Rate (2017-2022)
-
9.2 Global Point-of-Care Molecular Diagnostics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Infectious Diseases Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Oncology Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Hematology Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Prenatal Testing Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Endocrinology Consumption and Growth Rate (2017-2022)
-
9.2.6 Global Other Consumption and Growth Rate (2017-2022)
10 Global Point-of-Care Molecular Diagnostics Market Outlook by Types and Applications to 2028
-
10.1 Global Point-of-Care Molecular Diagnostics Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global PCR-based Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Genetic Sequencing-based Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Hybridization-based Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Microarray-based Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Point-of-Care Molecular Diagnostics Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Infectious Diseases Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Oncology Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Hematology Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Prenatal Testing Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Endocrinology Consumption Forecast and Growth Rate (2022-2028)
-
10.2.6 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Point-of-Care Molecular Diagnostics Import and Export Analysis (Top 5 Countries)
-
11.1 Global Point-of-Care Molecular Diagnostics Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Point-of-Care Molecular Diagnostics Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Point-of-Care Molecular Diagnostics Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Point-of-Care Molecular Diagnostics Market Competitive Analysis
-
14.1 Becton Dickinson Co
-
14.1.1 Becton Dickinson Co Company Details
-
14.1.2 Becton Dickinson Co Point-of-Care Molecular Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Becton Dickinson Co Point-of-Care Molecular Diagnostics Product and Service
-
14.2 Qiagen
-
14.2.1 Qiagen Company Details
-
14.2.2 Qiagen Point-of-Care Molecular Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Qiagen Point-of-Care Molecular Diagnostics Product and Service
-
14.3 Alere Inc
-
14.3.1 Alere Inc Company Details
-
14.3.2 Alere Inc Point-of-Care Molecular Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Alere Inc Point-of-Care Molecular Diagnostics Product and Service
-
14.4 Siemens Healthcare GmbH
-
14.4.1 Siemens Healthcare GmbH Company Details
-
14.4.2 Siemens Healthcare GmbH Point-of-Care Molecular Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Siemens Healthcare GmbH Point-of-Care Molecular Diagnostics Product and Service
-
14.5 Novartis AG
-
14.5.1 Novartis AG Company Details
-
14.5.2 Novartis AG Point-of-Care Molecular Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Novartis AG Point-of-Care Molecular Diagnostics Product and Service
-
14.6 Bio-Rad Laboratories Inc
-
14.6.1 Bio-Rad Laboratories Inc Company Details
-
14.6.2 Bio-Rad Laboratories Inc Point-of-Care Molecular Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Bio-Rad Laboratories Inc Point-of-Care Molecular Diagnostics Product and Service
-
14.7 Danaher Corporation
-
14.7.1 Danaher Corporation Company Details
-
14.7.2 Danaher Corporation Point-of-Care Molecular Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Danaher Corporation Point-of-Care Molecular Diagnostics Product and Service
-
14.8 Bayer AG
-
14.8.1 Bayer AG Company Details
-
14.8.2 Bayer AG Point-of-Care Molecular Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Bayer AG Point-of-Care Molecular Diagnostics Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Point-of-Care Molecular Diagnostics
-
Figure Point-of-Care Molecular Diagnostics Picture
-
Table Global Point-of-Care Molecular Diagnostics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Point-of-Care Molecular Diagnostics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Point-of-Care Molecular Diagnostics Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Point-of-Care Molecular Diagnostics Consumption by Country (2017-2022)
-
Figure United States Point-of-Care Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Table Europe Point-of-Care Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure China Point-of-Care Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Japan Point-of-Care Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure India Point-of-Care Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure South Korea Point-of-Care Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Global Point-of-Care Molecular Diagnostics Consumption Forecast by Country (2022-2028)
-
Figure United States Point-of-Care Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Point-of-Care Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Point-of-Care Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Point-of-Care Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Point-of-Care Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Point-of-Care Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global PCR-based Consumption and Growth Rate (2017-2022)
-
Figure Global Genetic Sequencing-based Consumption and Growth Rate (2017-2022)
-
Figure Global Hybridization-based Consumption and Growth Rate (2017-2022)
-
Figure Global Microarray-based Consumption and Growth Rate (2017-2022)
-
Figure Global Infectious Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Oncology Consumption and Growth Rate (2017-2022)
-
Figure Global Hematology Consumption and Growth Rate (2017-2022)
-
Figure Global Prenatal Testing Consumption and Growth Rate (2017-2022)
-
Figure Global Endocrinology Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global PCR-based Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Genetic Sequencing-based Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hybridization-based Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Microarray-based Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Infectious Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hematology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Prenatal Testing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Endocrinology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Point-of-Care Molecular Diagnostics Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Point-of-Care Molecular Diagnostics Export by Region (Top 5 Countries) (2017-2028)
-
Table Becton Dickinson Co (Foundation Year, Company Profile and etc.)
-
Table Becton Dickinson Co Point-of-Care Molecular Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Becton Dickinson Co Point-of-Care Molecular Diagnostics Product and Service
-
Table Qiagen (Foundation Year, Company Profile and etc.)
-
Table Qiagen Point-of-Care Molecular Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Qiagen Point-of-Care Molecular Diagnostics Product and Service
-
Table Alere Inc (Foundation Year, Company Profile and etc.)
-
Table Alere Inc Point-of-Care Molecular Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Alere Inc Point-of-Care Molecular Diagnostics Product and Service
-
Table Siemens Healthcare GmbH (Foundation Year, Company Profile and etc.)
-
Table Siemens Healthcare GmbH Point-of-Care Molecular Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Siemens Healthcare GmbH Point-of-Care Molecular Diagnostics Product and Service
-
Table Novartis AG (Foundation Year, Company Profile and etc.)
-
Table Novartis AG Point-of-Care Molecular Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis AG Point-of-Care Molecular Diagnostics Product and Service
-
Table Bio-Rad Laboratories Inc (Foundation Year, Company Profile and etc.)
-
Table Bio-Rad Laboratories Inc Point-of-Care Molecular Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bio-Rad Laboratories Inc Point-of-Care Molecular Diagnostics Product and Service
-
Table Danaher Corporation (Foundation Year, Company Profile and etc.)
-
Table Danaher Corporation Point-of-Care Molecular Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Danaher Corporation Point-of-Care Molecular Diagnostics Product and Service
-
Table Bayer AG (Foundation Year, Company Profile and etc.)
-
Table Bayer AG Point-of-Care Molecular Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer AG Point-of-Care Molecular Diagnostics Product and Service
-